Ameriprise’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.23M Sell
224,309
-71,844
-24% -$1.04M ﹤0.01% 2674
2025
Q1
$2.04M Sell
296,153
-33,835
-10% -$233K ﹤0.01% 2871
2024
Q4
$1.75M Buy
329,988
+224,399
+213% +$1.19M ﹤0.01% 2981
2024
Q3
$385K Buy
105,589
+85,499
+426% +$312K ﹤0.01% 3559
2024
Q2
$54.8K Buy
+20,090
New +$54.8K ﹤0.01% 3812
2023
Q1
Sell
-17,517
Closed -$29K 4041
2022
Q4
$29K Sell
17,517
-17,867
-50% -$29.6K ﹤0.01% 3881
2022
Q3
$44K Sell
35,384
-10,300
-23% -$12.8K ﹤0.01% 3890
2022
Q2
$76K Sell
45,684
-5,015
-10% -$8.34K ﹤0.01% 3806
2022
Q1
$125K Sell
50,699
-185
-0.4% -$456 ﹤0.01% 3821
2021
Q4
$190K Sell
50,884
-13,150
-21% -$49.1K ﹤0.01% 3792
2021
Q3
$401K Sell
64,034
-385
-0.6% -$2.41K ﹤0.01% 3473
2021
Q2
$635K Buy
64,419
+36,275
+129% +$358K ﹤0.01% 3370
2021
Q1
$263K Buy
28,144
+14,160
+101% +$132K ﹤0.01% 3632
2020
Q4
$67K Hold
13,984
﹤0.01% 3708
2020
Q3
$56K Hold
13,984
﹤0.01% 3667
2020
Q2
$64K Sell
13,984
-5
-0% -$23 ﹤0.01% 3608
2020
Q1
$46K Sell
13,989
-95
-0.7% -$312 ﹤0.01% 3585
2019
Q4
$61K Hold
14,084
﹤0.01% 3661
2019
Q3
$55K Hold
14,084
﹤0.01% 3655
2019
Q2
$65K Buy
+14,084
New +$65K ﹤0.01% 3661
2018
Q4
Sell
-14,827
Closed -$64K 3771
2018
Q3
$64K Buy
14,827
+500
+3% +$2.16K ﹤0.01% 3645
2018
Q2
$53K Buy
14,327
+2,500
+21% +$9.25K ﹤0.01% 3589
2018
Q1
$50K Buy
11,827
+275
+2% +$1.16K ﹤0.01% 3578
2017
Q4
$68K Buy
+11,552
New +$68K ﹤0.01% 3578
2017
Q1
Sell
-11,755
Closed -$39K 3681
2016
Q4
$39K Buy
+11,755
New +$39K ﹤0.01% 3805